|
|
|
 |
||
|
|
||
|
|
Produk Penyelidikan Komersil
TISSUE CULTURE FOWL POX VACCINE
Fowl pox virus causes
economic losses due to high morbidity, drop in egg production and mortality.
Previously the vaccine was prepared in embryonated eggs and delivered in
a wet form. Through extensive research, researchers of the Faculty
have successfully cloned a fowl pox virus that can be adapted to chick-embryo
fibroblast tissue culture.
The special features of this new clone are that it can grow well in tissue culture, giving a high titre and produces homogenous and high quality vaccine, which can be prepared in freeze-dried form.
This technique of preparation reduces operational costs and shortens production time per dose as compared with that using embryonated eggs. The vaccine is also more stable and has a long shelf-life.
This technology of fowl pox vaccine production in tissue-culture is the first to be developed in Malaysia. It is now produced commercially by Malaysian Vaccines and Pharmaceutical Sdn. Bhd. and the product was launched in 1995.
For further information regarding this product, please contact aiini@vet.upm.edu.my
UPM-V4
NEWCASTLE DISEASE VACCINE Virulent Newcastle
disease virus (NDV) is the world’s most lethal poultry virus. It
attacks the digestive, nervous and respiratory systems and can cause up
to 100% mortality in susceptible chicken. The disease can be controlled
by vaccination which is usually administered individually, by intranasal,
or intraocular routes, and the vaccine needs refrigeration. This
kind of vaccine made it impractical and difficult to administer to free
range chickens. The requirement for a ‘cold chain’ linking the manufacturer
of the vaccine to the recipient chicken makes using the vaccine very expensive. Researchers of the
Faculty have been successful in selecting V4 strain of NDV for extreme
heat resistance by sequential heat treatment and selection, and incubating
the cultures up to 56oC. The researchers also found ways to supply
the vaccine on some form of food, thus avoiding the need to catch chicken
individually. This vaccine can also be administered by conventional
routes. The vaccine has been
commercialised by Malaysian Vaccine and Pharmaceutical Sdn. Bhd. since
1993. For further information regarding this product, please contact aiini@vet.upm.edu.my
INNOVATIVE WHITE SPOT SYNDROME VIRUS (WSSV) DETECTION KIT
Since
1992, WSSV caused major losses to the shrimp industry in many Asian countries.
China recorded shrimp production loss of 80% that was equivalent to about
US$1 billion. In Malaysia losses in Sabah alone were estimated to be in
the region of RM 60 million. There is no treatment for the disease and
the only way to avoid losses is to screen the shrimp larvae before they
are introduced into the growout ponds.
This kit is the first that uses the advanced and automated single tube approach to detect WSSV, which is completely different from the conventional nested PCR method involving cumbersome two tubes and multiple-step procedures. This novel single tube method for shrimp virus is the first in the world and is patent pending.
The use of this kit to detect WSSV has saved millions of Ringgits and the shrimp industry in many countries. The kit is being sold in Australia, Indonesia, India, South America, Malaysia, Sri Lanka and Thailand.
For further information regarding this product, please contact shariff@vet.upm.edu.my
|
|
|
|
PENAFIAN :
Universiti Putra Malaysia tidak bertanggungjawab terhadap sebarang kehilangan
atau kerugian |
|
